about
Centrosome-declustering drugs mediate a two-pronged attack on interphase and mitosis in supercentrosomal cancer cells.HSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms in breast cancer patientsA novel microtubule-modulating agent EM011 inhibits angiogenesis by repressing the HIF-1α axis and disrupting cell polarity and migrationRational design of a protein that binds integrin αvβ3 outside the ligand binding site.Multi-institutional study of nuclear KIFC1 as a biomarker of poor prognosis in African American women with triple-negative breast cancerPreclinical Development of a Nontoxic Oral Formulation of Monoethanolamine, a Lipid Precursor, for Prostate Cancer Treatment.Precision detection of liver metastasis by collagen-targeted protein MRI contrast agentEarly detection and staging of chronic liver diseases with a protein MRI contrast agent
P50
Q34662347-277F2C7B-182C-416F-949E-5BCC58D62F3AQ35742468-B3185C57-9A5D-4988-8EA6-926DD51BD4AFQ36447016-A93D71BF-AAFC-4E8B-B3E8-2555F638DD17Q36974007-62D5D2D3-5B1A-4E36-A26E-8E964EE389C2Q37652330-8DF53CE3-90EF-4259-8A6E-240771C1A952Q38975512-463713A5-F9F0-4BBA-8F95-9FD3ADE83EB1Q90202183-CA10848A-3A80-4D43-B7E0-2B7A56E9114FQ90998913-2F490180-099A-4B64-A546-635D79F875BD
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ravi Chakra Turaga
@ast
Ravi Chakra Turaga
@en
Ravi Chakra Turaga
@es
Ravi Chakra Turaga
@nl
type
label
Ravi Chakra Turaga
@ast
Ravi Chakra Turaga
@en
Ravi Chakra Turaga
@es
Ravi Chakra Turaga
@nl
prefLabel
Ravi Chakra Turaga
@ast
Ravi Chakra Turaga
@en
Ravi Chakra Turaga
@es
Ravi Chakra Turaga
@nl
P106
P1153
55347341600
P31
P496
0000-0001-9075-7645